NEUFLEXIN Trademark

Trademark Overview

On Friday, April 25, 2014, a trademark application was filed for NEUFLEXIN with the United States Patent and Trademark Office. The USPTO has given the NEUFLEXIN trademark a serial number of 86262476. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 18, 2017. This trademark is owned by Mersana Therapeutics, Inc.. The NEUFLEXIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of oncological diseases and disorders
neuflexin

General Information

Serial Number86262476
Word MarkNEUFLEXIN
Filing DateFriday, April 25, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 18, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 16, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of oncological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 8, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMersana Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameMersana Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, December 18, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 18, 2017ABANDONMENT - NO USE STATEMENT FILED
Friday, May 5, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 4, 2017EXTENSION 5 GRANTED
Monday, May 1, 2017EXTENSION 5 FILED
Monday, May 1, 2017TEAS EXTENSION RECEIVED
Thursday, October 27, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 26, 2016EXTENSION 4 GRANTED
Monday, October 17, 2016EXTENSION 4 FILED
Monday, October 17, 2016TEAS EXTENSION RECEIVED
Wednesday, May 11, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 10, 2016EXTENSION 3 GRANTED
Monday, May 9, 2016EXTENSION 3 FILED
Monday, May 9, 2016TEAS EXTENSION RECEIVED
Wednesday, September 30, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 29, 2015EXTENSION 2 GRANTED
Tuesday, September 22, 2015EXTENSION 2 FILED
Monday, September 28, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 22, 2015TEAS EXTENSION RECEIVED
Friday, April 24, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 22, 2015EXTENSION 1 GRANTED
Wednesday, April 22, 2015EXTENSION 1 FILED
Wednesday, April 22, 2015TEAS EXTENSION RECEIVED
Tuesday, November 11, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 16, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 16, 2014PUBLISHED FOR OPPOSITION
Wednesday, August 27, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 8, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 8, 2014ASSIGNED TO EXAMINER
Thursday, May 8, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 29, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

neuflexin diseases disorders oncological treatment preparations pharmaceutical